source
- STAT+: Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer's drugs.STAT · 2mo ago↗ source
- No FDA permission, no problem: New flavored vape policy worries expertsA new FDA policy will let some flavored vapes stay on the market without authorization.STAT · 2mo ago↗ source
- GSK cuts deal with Sino to broaden reach of hepatitis B drugThe marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access to a therapy called bepirovirsen that’s important to its future.BioPharma Dive · 2mo ago↗ source